Cargando…
Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response
BACKGROUND: Glutathione S‐transferases (GSTs) polymorphisms may impact on chronic myeloid leukemia (CML) risk or heterogeneous responses to Imatinib mesylate (IM). The aim of this study was to evaluate the correlation between GSTs polymorphisms and CML risk, treatment response. METHODS: We genotyped...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625153/ https://www.ncbi.nlm.nih.gov/pubmed/31111691 http://dx.doi.org/10.1002/mgg3.717 |
_version_ | 1783434362195279872 |
---|---|
author | Rostami, Golale Assad, Dlnya Ghadyani, Fatemeh Hamid, Mohammad Karami, Amirhossien Jalaeikhoo, Hasan Kalahroodi, Ramezan Ali |
author_facet | Rostami, Golale Assad, Dlnya Ghadyani, Fatemeh Hamid, Mohammad Karami, Amirhossien Jalaeikhoo, Hasan Kalahroodi, Ramezan Ali |
author_sort | Rostami, Golale |
collection | PubMed |
description | BACKGROUND: Glutathione S‐transferases (GSTs) polymorphisms may impact on chronic myeloid leukemia (CML) risk or heterogeneous responses to Imatinib mesylate (IM). The aim of this study was to evaluate the correlation between GSTs polymorphisms and CML risk, treatment response. METHODS: We genotyped GSTM1, GSTT1 null deletion polymorphisms, and GSTP1 Ile105Val polymorphism by PCR methods and BCR‐ABL transcripts were analyzed by qRT‐PCR in 104 CML patients and 104 sex‐ and age‐matched healthy individuals. RESULTS: Individual analysis showed significant association of GSTM1 (p = 0.008; OR = 0.46; 95% CI: 0.26–0.82) and GSTP1 genes (p = 0.04; OR = 1.56; 95% CI: 1.016–2.423) with CML risk. The combined analysis indicated that GSTM1 null/GSTT1 present, GSTM1‐null/GSTP1M*(AG/GG) as well as GSTT1 present/ GSTP1M* genotype were associated with CML risk (ORg(‐):2.28; 95% CI: 1.29–4.04; ORgg: 2.85; 95% CI: 1.36–5.97; OR(‐)g: 1.75; 95% CI: 0.99–3.06, respectively). The proportion of CML cancer attributable to the interaction of smoking and GSTM1 null, GSTT1null, and GSTP1 M* was 42%, 39%, and 13%, respectively. Patients with GSTM1‐null and GSTP1 AG/GG genotype had significantly a lower rate of MMR achievement (p = 0.00; p = 0.009 respectively). Event‐free survival (EFS) percentage was similar between GSTM1 null and GSTM1 present patients (p = 0.21). CONCLUSION: Our study suggests the influence of GSTM1 and GSTP1 polymorphisms on CML risk and treatment response. The interaction between GSTs polymorphisms and smoking plays a significant role on CML susceptibility. |
format | Online Article Text |
id | pubmed-6625153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66251532019-07-17 Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response Rostami, Golale Assad, Dlnya Ghadyani, Fatemeh Hamid, Mohammad Karami, Amirhossien Jalaeikhoo, Hasan Kalahroodi, Ramezan Ali Mol Genet Genomic Med Original Articles BACKGROUND: Glutathione S‐transferases (GSTs) polymorphisms may impact on chronic myeloid leukemia (CML) risk or heterogeneous responses to Imatinib mesylate (IM). The aim of this study was to evaluate the correlation between GSTs polymorphisms and CML risk, treatment response. METHODS: We genotyped GSTM1, GSTT1 null deletion polymorphisms, and GSTP1 Ile105Val polymorphism by PCR methods and BCR‐ABL transcripts were analyzed by qRT‐PCR in 104 CML patients and 104 sex‐ and age‐matched healthy individuals. RESULTS: Individual analysis showed significant association of GSTM1 (p = 0.008; OR = 0.46; 95% CI: 0.26–0.82) and GSTP1 genes (p = 0.04; OR = 1.56; 95% CI: 1.016–2.423) with CML risk. The combined analysis indicated that GSTM1 null/GSTT1 present, GSTM1‐null/GSTP1M*(AG/GG) as well as GSTT1 present/ GSTP1M* genotype were associated with CML risk (ORg(‐):2.28; 95% CI: 1.29–4.04; ORgg: 2.85; 95% CI: 1.36–5.97; OR(‐)g: 1.75; 95% CI: 0.99–3.06, respectively). The proportion of CML cancer attributable to the interaction of smoking and GSTM1 null, GSTT1null, and GSTP1 M* was 42%, 39%, and 13%, respectively. Patients with GSTM1‐null and GSTP1 AG/GG genotype had significantly a lower rate of MMR achievement (p = 0.00; p = 0.009 respectively). Event‐free survival (EFS) percentage was similar between GSTM1 null and GSTM1 present patients (p = 0.21). CONCLUSION: Our study suggests the influence of GSTM1 and GSTP1 polymorphisms on CML risk and treatment response. The interaction between GSTs polymorphisms and smoking plays a significant role on CML susceptibility. John Wiley and Sons Inc. 2019-05-20 /pmc/articles/PMC6625153/ /pubmed/31111691 http://dx.doi.org/10.1002/mgg3.717 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Rostami, Golale Assad, Dlnya Ghadyani, Fatemeh Hamid, Mohammad Karami, Amirhossien Jalaeikhoo, Hasan Kalahroodi, Ramezan Ali Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response |
title | Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response |
title_full | Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response |
title_fullStr | Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response |
title_full_unstemmed | Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response |
title_short | Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response |
title_sort | influence of glutathione s‐transferases (gstm1, gstt1, and gstp1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625153/ https://www.ncbi.nlm.nih.gov/pubmed/31111691 http://dx.doi.org/10.1002/mgg3.717 |
work_keys_str_mv | AT rostamigolale influenceofglutathionestransferasesgstm1gstt1andgstp1geneticpolymorphismsandsmokingonsusceptibilityriskofchronicmyeloidleukemiaandtreatmentresponse AT assaddlnya influenceofglutathionestransferasesgstm1gstt1andgstp1geneticpolymorphismsandsmokingonsusceptibilityriskofchronicmyeloidleukemiaandtreatmentresponse AT ghadyanifatemeh influenceofglutathionestransferasesgstm1gstt1andgstp1geneticpolymorphismsandsmokingonsusceptibilityriskofchronicmyeloidleukemiaandtreatmentresponse AT hamidmohammad influenceofglutathionestransferasesgstm1gstt1andgstp1geneticpolymorphismsandsmokingonsusceptibilityriskofchronicmyeloidleukemiaandtreatmentresponse AT karamiamirhossien influenceofglutathionestransferasesgstm1gstt1andgstp1geneticpolymorphismsandsmokingonsusceptibilityriskofchronicmyeloidleukemiaandtreatmentresponse AT jalaeikhoohasan influenceofglutathionestransferasesgstm1gstt1andgstp1geneticpolymorphismsandsmokingonsusceptibilityriskofchronicmyeloidleukemiaandtreatmentresponse AT kalahroodiramezanali influenceofglutathionestransferasesgstm1gstt1andgstp1geneticpolymorphismsandsmokingonsusceptibilityriskofchronicmyeloidleukemiaandtreatmentresponse |